We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Portable Real-Time PCR System Resolves Problems of Limited Lab Space and Fragmented Samples

By LabMedica International staff writers
Posted on 24 Feb 2023

Today, laboratories that are inside as well as outside of the hospital environment face the challenge of functioning in a limited space while ensuring that the quality of work being carried out is not impacted by the lack of room for equipment. More...

Now, a new portable real-time PCR system designed for mobile or small laboratories or on-site testing solves the problem of limited space and fragmented samples in laboratories.

Tianlong Science and Technology (Shaanxi, China) has launched the new Gentier Mini+ real-time PCR system for mobile or small laboratories or on-site testing that is portable, fast, and always online. Designed for excellent performance and portability, the revolutionary Gentier Mini+ solves the problem of limited space and fragmented samples in laboratories to make workflow easier, more accurate, and more efficient.

The Gentier Mini+ is an updated model of the Gentier Mini with two fluorescence channels that had proved popular among Tianlong’s clients. In order to fully meet the needs of its clients, Tianlong has launched the Gentier Mini+ which now comes with four channels, enabling a 16 sample throughput that makes it suitable for more applications. The Gentier Mini+ can be utilized for a variety of applications in the fields of animal and human infectious disease prevention and control, food safety and scientific research, among others.

Related Links:
Tianlong Science and Technology


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
Clinical Informatics Platform
CLARION™
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.